French Medics Sued Over CJD Deaths
Featured ArticleMain Category: CJD / vCJD / Mad Cow Disease
Also Included In: Litigation / Medical Malpractice
Article Date: 07 Feb 2008 - 11:00 PDT
| Patient / Public: | ![]() |
4.5 (4 votes) |
| Healthcare Prof: | ![]() |
4.5 (6 votes) |
| Article Opinions: | 1 posts |
Seven former medical officials are on trial in France following a 17 year investigation into over 100 deaths from Creutzfeldt-Jakob disease (CJD) of young patients treated with contaminated growth hormones.
The defendants, retired doctors and pharmacists in their 70s and 80s, are accused of manslaughter, aggravated deception and causing unintentional injury, said Reuters news agency.
111 French children and young people have died and over 800 others are at risk of CJD, an incurable disease where the brain gradually wastes away, and whose symptoms can take up to 40 years to appear.
Francine Delbrel, a member of one of the victims' associations bringing the case against the defendants told the press that:
"Each time we have thought that the danger is passing a new death arrives to dash our hopes."
Her daughter Benedicte, died when she was 21 years old, in 1993. Her doctors were not able to diagnose the disease, said Times Online.
The trial started yesterday, Wednesday 6th February, in a Paris courtroom packed with 200 relatives of the victims. If convicted the defendants could be sentenced to serve 4 years. One defendant, a pharmacology professor, who is also charged with corruption for accepting bribes, could serve 10 years, according to Guardian Unlimited.
The prosecution will be using the results of a long and complex investigation that took 17 years and looked into many aspects of the cases and the events surrounding them.
Doctors in France continued to treat children with stunted growth using hormones harvested from the pituitary glands of dead humans until the late 1980s. Other countries, the US and Britain included, stopped using human derived growth hormones in 1985 and switched to synthetic versions, after a young American was thought to have died from CJD caught from infected human hormones.
Meanwhile in France, pituitary glands continued to be harvested from human corpses, although procedures were supposed to be tightened up, until 1988. The prosecution case relies on allegations that the the preparation and harvesting methods did not follow the new procedures and that in some cases untrained staff were involved.
Many of the thousands of organs bought by the accused during the 1980s came from Bulgaria and Hungary, said the investigation report, and in some cases the staff of one of the team members took them from bodies in neurological or geriatric wards or from a hospital specializing in infectious diseases. The investigators also found evidence that operation theatre ordelies had been paid small sums for pituitary glands.
The families of CJD victims came together and decided to sue after a French teenager died of CJD in 1992.
Another factor likely to count against the defendants is that the institute where the team worked had been warned in 1980 that the human version of the hormone could be a source of CJD. This warning came from Luc Montagnier, the scientist who identified the AIDS virus, said Reuters.
The defendants are apparently not denying that they made mistakes, but they argue scientists did not know at the time about the risks linking CJD with human growth hormone. There was speculation, but no high degree of certainty, and it was not until 1990 that the link between CJD and the pituitary gland was established.
One of the defence lawyers, Benoit Chabert, told the press that the defendants "acted based on the state of knowledge at the time," and that it is easy to say today, over 20 years later, that the risk was there, "but in 1983, in 1985, was the risk certain?" he asked.
The court will be hearing evidence from over 20 expert witnesses, said Times Online, including 1997 Nobel Prize Winner for Medicine, Stanley Prusiner, the scientist who discovered prions.
Prions are small proteins that cause a range of brain degenerative diseases such as CJD in humans and bovine spongiform encephalopathy (BSE, or "mad cow disease") in cattle. The prions from the infected source get into the brain and play havoc with the new host's neural protein, making it fold into shapes that disrupt the tissue structure and function of the brain.
Sources: Times Online, Guardian Unlimited, Reuters.
Written by: Catharine Paddock, PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/articles/96593.php>
APA
http://www.medicalnewstoday.com/articles/96593.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Growth Hormone And CJD Deaths?
posted by Josef Hlasny on 14 Feb 2008 at 6:56 amNeurodegenerative diseases, including BSE, Alzheimer’s disease etc. are caused by different mechanisms but may share a final common pathway to neuronal injury due to the overstimulation of glutamate receptors, especially of the N-methyl-D -aspartate (NMDA) receptor subtype.
It is generally accepted that the influx of Ca2+ as a result of excessive activation of the NMDA receptor underlies the toxic actions of glutamate in many systems. On the other hand, Mg2+ competes with Ca2+ at voltage- gated calcium channels both intracellularly and on the cell surface membrane. So, Mg2+ can protect against NMDA- induced neurodegeneration and Ca2+ deficiency can be important about NMDA hypofunction (e.g. in schizophrenia).
However, there is also evidence for a pivotal role of glutamate pathways in the regulation of growth hormone (GH) secretion; so activation of NMDA receptors stimulates growth hormone (GH) secretion. GH deficiency results from a failure of the pituitary gland to make sufficient amounts of the hormone. According to the 1994 Utah Growth Hormone Study, growth hormone deficiency occurs in 1 out of every 3,480 children.
The largest study of its kind has found that the vast majority of those who received the GH from cadavers did not contract the fatal condition. However, some recipients- individuals (26 out of approximately 7,700) did develop the CJD.
Because of their central role in neurodegeneration, NMDA receptors have been considered prime therapeutic targets for the development of useful neuroprotective strategies. However, in some individuals, NMDA receptors may differ in their sensitivity to voltage-dependent Mg2+ block, agonists, and antagonists as a function of their subunit composition. So there is a question; is there a link about some recipients – individuals (CJD developing) and the NMDA receptors sensitivity in some individuals? If yes, then “growth hormone and CJD deaths”, are not a connection with an “infectious disease”;more details see my website http://www.bse-expert.cz.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



